Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$734,051
+$322,914 QoQ
Shares Held
612
+36.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#3,402
of 4,605 holders
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inspire Advisors, LLC holds $3,715,739 across 7 Drug Manufacturers - General names. LLY ranks #3 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
31,554 | $759,820 | |
| 2 | ABBV |
AbbVie Inc.
|
2,940 | $739,821 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
612 | $734,051 | |
| 4 | JNJ |
Johnson & Johnson
|
2,106 | $534,860 | |
| 5 | AMGN |
Amgen Inc
|
988 | $357,774 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,474 | $317,909 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,149 | $271,504 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $734,051 | 612 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $411,137 | 447 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $240,728 | 224 | Shares | Sole | 2026-02-13 | |
| 2023-12-31 | $237,248 | 407 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $225,594 | 420 | Shares | Sole | 2023-10-26 | |
| No filing history on record for this holder in this stock. | ||||||